![If you say “We are confused Doctor what is CIN ? What is LSIL?”, come to this section | Genital Siğil - HPV - Human Papilloma Virus If you say “We are confused Doctor what is CIN ? What is LSIL?”, come to this section | Genital Siğil - HPV - Human Papilloma Virus](https://hpv.com.tr/wp-content/uploads/2013/02/Servikal-Dispalzi-Tablosu.jpg)
If you say “We are confused Doctor what is CIN ? What is LSIL?”, come to this section | Genital Siğil - HPV - Human Papilloma Virus
![Immunohistochemical detection of human papillomavirus capsid proteins L1 and L2 in squamous intraepithelial lesions: potential utility in diagnosis and management | Modern Pathology Immunohistochemical detection of human papillomavirus capsid proteins L1 and L2 in squamous intraepithelial lesions: potential utility in diagnosis and management | Modern Pathology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fmodpathol.2012.156/MediaObjects/41379_2013_Article_BFmodpathol2012156_Fig1_HTML.jpg)
Immunohistochemical detection of human papillomavirus capsid proteins L1 and L2 in squamous intraepithelial lesions: potential utility in diagnosis and management | Modern Pathology
![Cancers | Free Full-Text | Review of the Standard and Advanced Screening, Staging Systems and Treatment Modalities for Cervical Cancer | HTML Cancers | Free Full-Text | Review of the Standard and Advanced Screening, Staging Systems and Treatment Modalities for Cervical Cancer | HTML](https://www.mdpi.com/cancers/cancers-14-02913/article_deploy/html/images/cancers-14-02913-g002.png)
Cancers | Free Full-Text | Review of the Standard and Advanced Screening, Staging Systems and Treatment Modalities for Cervical Cancer | HTML
![Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management. - Abstract - Europe PMC Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3616418/bin/nihms440304f1.jpg)
Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management. - Abstract - Europe PMC
![p16 staining has limited value in predicting the outcome of histological low-grade squamous intraepithelial lesions of the cervix | Modern Pathology p16 staining has limited value in predicting the outcome of histological low-grade squamous intraepithelial lesions of the cervix | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fmodpathol.2015.126/MediaObjects/41379_2016_Article_BFmodpathol2015126_Fig1_HTML.jpg)
p16 staining has limited value in predicting the outcome of histological low-grade squamous intraepithelial lesions of the cervix | Modern Pathology
![Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers | Journal of Clinical Pathology Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers | Journal of Clinical Pathology](https://jcp.bmj.com/content/jclinpath/59/10/1017/F1.large.jpg)